Related Experiment Video
Updated: May 10, 2025

12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
15.8K
[Towards using pseudo-prions against neurodegenerative diseases]
Marc Dhenain1, Marina Celestine1, Muriel Jacquier-Sarlin2
1CNRS, Université Paris-Saclay, Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Laboratoire des maladies neurodégénératives, Fontenay-aux-Roses, France - CEA, Direction de la recherche fondamentale (DRF), Institut de biologie François Jacob MIRCen, Fontenay-aux-Roses, France.
Summary
No abstract available in PubMed .
Related Concept Videos
Parkinson's Disease: Overview
308
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
308
Amyloid Fibrils
9.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.0K

